Clinical trial
The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases
NCT02809170 is registered in ClinicalTrials.gov with Tawam Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases
- Lead sponsor
- Tawam Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- June 30, 2019
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.